385 related articles for article (PubMed ID: 24094453)
21. Discrepant association of serum C-3 epimer of 25-hydroxyvitamin D versus non-epimeric 25-hydroxyvitamin D with serum lipid levels.
Chailurkit LO; Aekplakorn W; Srijaruskul K; Ongphiphadhanakul B
Lipids Health Dis; 2016 Sep; 15(1):157. PubMed ID: 27633775
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D Deficient Older Adults Are More Prone to Have Metabolic Syndrome, but Not to a Greater Number of Metabolic Syndrome Parameters.
Pott-Junior H; Nascimento CMC; Costa-Guarisco LP; Gomes GAO; Gramani-Say K; Orlandi FS; Gratão ACM; Orlandi AADS; Pavarini SCI; Vasilceac FA; Zazzetta MS; Cominetti MR
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32178228
[TBL] [Abstract][Full Text] [Related]
23. Deficient serum 25-hydroxyvitamin D is associated with an atherogenic lipid profile: The Very Large Database of Lipids (VLDL-3) study.
Lupton JR; Faridi KF; Martin SS; Sharma S; Kulkarni K; Jones SR; Michos ED
J Clin Lipidol; 2016; 10(1):72-81.e1. PubMed ID: 26892123
[TBL] [Abstract][Full Text] [Related]
24. Effect of climate therapy at Gran Canaria on vitamin D production, blood glucose and lipids in patients with psoriasis.
Osmancevic A; Nilsen LT; Landin-Wilhelmsen K; Søyland E; Abusdal Torjesen P; Hagve TA; Nenseter MS; Krogstad AL
J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1133-40. PubMed ID: 19453805
[TBL] [Abstract][Full Text] [Related]
25. Altered Lipid Metabolism in Blood Mononuclear Cells of Psoriatic Patients Indicates Differential Changes in Psoriasis Vulgaris and Psoriatic Arthritis.
Wójcik P; Biernacki M; Wroński A; Łuczaj W; Waeg G; Žarković N; Skrzydlewska E
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480263
[TBL] [Abstract][Full Text] [Related]
26. Association of 25-hydroxyvitamin D with metabolic syndrome in patients with psoriasis: a case-control study.
Orgaz-Molina J; Magro-Checa C; Arrabal-Polo MA; Raya-Álvarez E; Naranjo R; Buendía-Eisman A; Arias-Santiago S
Acta Derm Venereol; 2014 Mar; 94(2):142-5. PubMed ID: 23995104
[TBL] [Abstract][Full Text] [Related]
27. Association Between Cardiovascular Risk Factors and 25(OH)D Levels in Obese Patients.
Curvello-Silva KL; Oliveira NA; Silva TSS; Sousa CD; Daltro C
Metab Syndr Relat Disord; 2020 Sep; 18(7):328-332. PubMed ID: 32513042
[No Abstract] [Full Text] [Related]
28. Associations of serum 25-hydroxyvitamin D and components of the metabolic syndrome in obese adolescent females.
Ashraf AP; Alvarez JA; Gower BA; Saenz KH; McCormick KL
Obesity (Silver Spring); 2011 Nov; 19(11):2214-21. PubMed ID: 21546933
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D, metabolic dyslipidemia, and metabolic syndrome in rheumatoid arthritis.
Baker JF; Mehta NN; Baker DG; Toedter G; Shults J; Von Feldt JM; Leonard MB
Am J Med; 2012 Oct; 125(10):1036.e9-1036.e15. PubMed ID: 22800875
[TBL] [Abstract][Full Text] [Related]
30. Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire.
Barrea L; Macchia PE; Tarantino G; Di Somma C; Pane E; Balato N; Napolitano M; Colao A; Savastano S
J Transl Med; 2015 Sep; 13():303. PubMed ID: 26376719
[TBL] [Abstract][Full Text] [Related]
31. 25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity.
Muscogiuri G; Sorice GP; Prioletta A; Policola C; Della Casa S; Pontecorvi A; Giaccari A
Obesity (Silver Spring); 2010 Oct; 18(10):1906-10. PubMed ID: 20150902
[TBL] [Abstract][Full Text] [Related]
32. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab).
Gagnon C; Lu ZX; Magliano DJ; Dunstan DW; Shaw JE; Zimmet PZ; Sikaris K; Ebeling PR; Daly RM
J Clin Endocrinol Metab; 2012 Jun; 97(6):1953-61. PubMed ID: 22442263
[TBL] [Abstract][Full Text] [Related]
33. 25-hydroxyvitamin D is associated with adiposity and cardiometabolic risk factors in a predominantly vitamin D-deficient and overweight/obese but otherwise healthy cohort.
Mousa A; Naderpoor N; de Courten MPJ; Scragg R; de Courten B
J Steroid Biochem Mol Biol; 2017 Oct; 173():258-264. PubMed ID: 28007531
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids.
Jorde R; Grimnes G
Prog Lipid Res; 2011 Oct; 50(4):303-12. PubMed ID: 21640757
[TBL] [Abstract][Full Text] [Related]
35. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
[TBL] [Abstract][Full Text] [Related]
36. The relevance of serum vitamin D in psoriasis: a review.
Hambly R; Kirby B
Arch Dermatol Res; 2017 Sep; 309(7):499-517. PubMed ID: 28674914
[TBL] [Abstract][Full Text] [Related]
37. Hyperuricemia in patients with chronic plaque psoriasis.
Gisondi P; Targher G; Cagalli A; Girolomoni G
J Am Acad Dermatol; 2014 Jan; 70(1):127-30. PubMed ID: 24183485
[TBL] [Abstract][Full Text] [Related]
38. Bone Mineral Density, 25-OH Vitamin D and Inflammation in Patients with Psoriasis.
Solak B; Dikicier BS; Celik HD; Erdem T
Photodermatol Photoimmunol Photomed; 2016 May; 32(3):153-60. PubMed ID: 26869073
[TBL] [Abstract][Full Text] [Related]
39. Effect of Vitamin D on Peripheral Blood Mononuclear Cells from Patients with Psoriasis Vulgaris and Psoriatic Arthritis.
Cubillos S; Krieg N; Norgauer J
PLoS One; 2016; 11(4):e0153094. PubMed ID: 27050092
[TBL] [Abstract][Full Text] [Related]
40. Relationships between n-3 polyunsaturated fatty acid intake, serum 25 hydroxyvitamin D, food consumption, and nutritional status among adolescents.
Lopes MP; Giudici KV; Marchioni DM; Fisberg RM; Martini LA
Nutr Res; 2015 Aug; 35(8):681-8. PubMed ID: 26094211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
